Certain teens more likely to get hooked on opioids

March 12, 2018 by Dennis Thompson, Healthday Reporter

(HealthDay)—Teenagers with any mental health problem are more prone to painkiller dependence after receiving a prescription opioid, a new study finds.

The odds of progressing to long-term therapy can double, triple or more, depending on the kid's diagnosis and the other drugs prescribed to treat their disorder, the researchers said.

The findings mirror earlier studies showing that adults with are more likely to take on a long-term basis, said study author Patrick Quinn.

Doctors prescribing drugs like oxycodone (OxyContin) or hydrocodone (Vicodin) for chronic pain might want to screen for mental disorders, said Quinn, a postdoctoral fellow with Indiana University, in Bloomington. If there's a deeper psychiatric problem driving their pain, it might be addressed without resorting to addictive narcotics.

This study highlights that these patients "might be already carrying some risk for [addiction] problems, even before they start taking opioids," Quinn added.

Faced with an epidemic of opioid addiction in the United States, researchers are trying to determine who is most vulnerable. Quinn and his colleagues analyzed commercial health insurance records for more than 1.2 million teens, aged 14 to 18, who had been prescribed an opioid.

The researchers looked to see if the had a previous diagnosis of a mental condition, including anxiety, mood disorders, attention-deficit/hyperactivity disorder, psychosis, sleep disorders or substance abuse problems.

The investigators then looked past the initial prescription to see whether these teens were more likely to end up taking opioids on a long-term basis.

Overall, about three out of every 1,000 teenagers prescribed opioids wound up taking them long-term, Quinn said.

But those numbers were consistently higher for teens struggling with mental disorders:

  • 7 out of 1,000 teens with schizophrenia.
  • 8 out of 1,000 teens with anxiety disorders.
  • 9 out of 1,000 teens with depression.
  • 10 out of 1,000 teens with bipolar disorder.
  • 11 out of 1,000 teens with a sleep disorder.

Kids already taking a psychoactive medication for their were even more likely to wind up on opioids long-term. For example, odds rose higher for teens with anxiety who take benzodiazepines (such as Xanax); kids with mood who take an SNRI (such as Cymbalta); and those taking antipsychotics for schizophrenia (such as Abilify).

The study, published online March 12 in JAMA Pediatrics, didn't examine the reasons for the higher odds of painkiller dependence.

But it might be that their underlying mental disorder makes them more likely to feel their pain more intensely or persistently, Quinn said.

These teens also might come in to doctors' offices in more obvious need of immediate care, prompting doctors to reach for opioids as a powerful treatment, he added.

"They're displaying more distress and showing more need to be taken care of," Quinn said.

Based on this study, doctors should do a little more digging before they hand out an opioid prescription, said Dr. Scott Krakower. He's assistant unit chief of psychiatry at Zucker Hillside Hospital in Glen Oaks, N.Y.

"We need to spend more time trying to figure things out as opposed to just jumping to a medication for patients who may not have needed that opioid agent," Krakower said. "If you're writing [the prescription for] the opioid agent, maybe it's a good idea for you to make sure you're not missing other pieces that are going on with the case."

Treating teens' mental problems could help ease their pain, Krakower suggested. He wasn't involved in the new study.

Doctors also could reach for less powerful and addictive pain relievers, Krakower and Quinn said. Both noted a recent study in the Journal of the American Medical Association that found that over-the-counter remedies such as acetaminophen (Tylenol) or ibuprofen (Motrin, Advil) are better than opioids at easing the intensity of chronic back pain.

On the other hand, some mentally disturbed teens will legitimately need an opioid to treat pain after surgery, for example, Krakower said.

In those cases, doctors need to make sure the patients and their families understand that this will not become a long-term treatment.

Still, Krakower said patients need to be told, "We're going to do a short-term supply to get through the hurdles, and there's going to be an end point."

Explore further: Opioid dependence can start in just a few days

More information: Patrick D. Quinn et al. Association of Mental Health Conditions and Treatments With Long-term Opioid Analgesic Receipt Among Adolescents, JAMA Pediatrics (2018). DOI: 10.1001/jamapediatrics.2017.5641

Related Stories

Opioid dependence can start in just a few days

March 16, 2017
(HealthDay)—Doctors who limit the supply of opioids they prescribe to three days or less may help patients avoid the dangers of dependence and addiction, a new study suggests.

Psychiatric conditions linked to increased risk of long-term opioid use

December 29, 2016
A wide range of pre-existing psychiatric and behavioral conditions and the use of psychoactive drugs could be important risk factors leading to long-term use of opioid pain medications, reports a study in Pain, the official ...

How to avoid opioid addiction after surgery

January 30, 2018
(HealthDay)—Following surgery, many patients head home with prescriptions for 30 or more opioid painkillers—enough to trigger addiction, warns a leading group of anesthesiologists.

Plastic surgeons get tips on managing opioid addiction risk

October 2, 2017
Opioid medications prescribed for pain management after plastic surgery may contribute to the ongoing opioid epidemic, according to a special topic paper in the October issue of Plastic and Reconstructive Surgery, the official ...

Nearly 10 million U.S. adults suffer from mental illness

June 13, 2017
(HealthDay)—Nearly 10 million American adults have a serious mental illness, and a similar number have considered suicide during the past year, according to a new government report on the nation's behavioral ills.

Drugstore pain pills as effective as opioids in ER patients

November 7, 2017
Emergency rooms are where many patients are first introduced to powerful opioid painkillers, but what if doctors offered over-the-counter pills instead? A new study tested that approach on patients with broken bones and sprains ...

Recommended for you

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

Opioid prescriptions from dentists linked to youth addiction risk

December 3, 2018
Teens and young adults who receive their initial opioid prescriptions from their dentists or oral surgeons are at increased risk for opioid addiction in the following year, a study from the Stanford University School of Medicine ...

Rise in meth and opioid use during pregnancy

November 29, 2018
Amphetamine and opioid use in pregnancy increased substantially over the last decade in the United States, a new Michigan Medicine-led study finds. And a disproportionate rise occurred in rural counties.

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.